Send mail to Author

Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial) (Article)

Please indicate your contact information and select, which author you want to contact.



 
  ______     ___      _  _    __   __    _  _      ___    
 /_   _//   / _ \\   | \| ||  \ \\/ //  | \| ||   / _ \\  
 `-| |,-   | / \ ||  |  ' ||   \ ` //   |  ' ||  / //\ \\ 
   | ||    | \_/ ||  | .  ||    | ||    | .  || |  ___  ||
   |_||     \___//   |_|\_||    |_||    |_|\_|| |_||  |_||
   `-`'     `---`    `-` -`     `-`'    `-` -`  `-`   `-` 
                                                          
 


Back to frontdoor view